Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Healthcare Biotechnology
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > From Twitter
View:
Post by archeo753 on Aug 22, 2023 4:26pm

From Twitter

https://twitter.com/Theratech_/status/1694079500252746136

Theratechnologies
 
@Theratech_
 
 Delighted to share that 3 clinical sites are actively recruiting #OvarianCancer patients for our Phase 1 clinical trial of #TH1902. Full details  clinicaltrials.gov/study/NCT04706
*S " ", *
Comment by palinc2000 on Aug 22, 2023 4:49pm
Great find!!!  
Comment by mikeq113 on Aug 22, 2023 4:54pm
Utterly absurd that this isn't being blasted in a PR by the company.
Comment by mikeq113 on Aug 22, 2023 4:56pm
Our stock price is hemorrhaging, we're trading at a fraction of 1 times sales with a market cap of 23 million...let's just tweet it.
Comment by Johnnycash23 on Aug 22, 2023 5:01pm
This contradicts the corporate presentation that was published today! For God sake!
Comment by Trogarzon on Aug 22, 2023 5:12pm
Ok so this news appears on X (Twitter) and Linked In but no PR... maybe tomorrow AM and we go back above 1$... woo hoo...
Theratechnologies Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities